Graft-versus-host disease (GVHD) is a common side effect of an allogeneic transplant (transplant using donor cells) that can affect many organs. This presentation describes how GVHD can affect the gut, and strategies to prevent and treat it.

This presentation discusses CAR T-cell therapy for multiple myeloma. It explains what CAR T-cell therapy is, the process, and what clinical trials are indicating in regards to short- and long-term side effects, patient outcomes, and quality of life.

CAR T cell therapy has become an increasingly common treatment for patients with diffuse large B-cell lymphoma, (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma. This presentation discusses how it works, who is a good candidates for CAR T-cell therapy, and the risks and benefits of the treatment.

When graft-versus-host disease (GVHD) affects the mouth (oral GVHD), it can cause pain, problems with eating, and speech difficulties. This video discusses symptoms of oral GVHD, treatment options, and what patients can do to help manage the problem.